BTMD - biote Corp - Ordinary Shares - Class A
IEX Last Trade
6.28
0.030 0.478%
Share volume: 110,112
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$6.25
0.03
0.48%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2023-05-12 | 2023-08-11 | 2023-11-13 | 2024-03-15 | |
| Total revenue | 44.843 M | 49.257 M | 45.557 M | 45.703 M | |
| Cost of revenue | 13.877 M | 15.828 M | 14.167 M | 14.005 M | |
| Gross profit | 30.966 M | 33.429 M | 31.390 M | 31.698 M | |
| 7.95% | -6.10% | 0.98% | |||
| Operating expenses | 23.085 M | 25.760 M | 23.791 M | 26.190 M | |
| Selling general and admin | 23.085 M | 25.760 M | 23.791 M | 26.190 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 36.962 M | 41.588 M | 37.958 M | 40.195 M | |
| 12.52% | -8.73% | 5.89% | |||
| Operating income | 7.881 M | 7.669 M | 7.599 M | 5.508 M | |
| Ebit | 7.881 M | 7.669 M | 7.599 M | 5.508 M | |
| Pretax income | -20.800 M | -12.173 M | 23.516 M | 9.334 M | |
| -41.48% | -293.18% | -60.31% | |||
| Income tax | 630.000 K | 922.000 K | 3.874 M | -2.744 M | |
| Net income basic | -6.805 M | -5.143 M | 7.530 M | 7.734 M | |
| 24.42% | 246.41% | 2.71% | |||
| Net income | -6.805 M | -5.143 M | 7.530 M | 7.734 M | |
| 24.42% | 246.41% | 2.71% |